This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
HIV Infections
and you are
between 18 and 50
years old
-
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

HVTN 908 is a sub study of the HIV vaccine trial, HVTN 205. The purpose of this sub study is to better understand how a person's immune system responds to vaccines, particularly HIV vaccines. More specifically, researchers will determine whether early responses in the immune system help predict strong and long-lasting immunity.

Provided treatments

  • Biological: JS7 DNA vaccine
  • Biological: MVA/HIV62 vaccine
Tris trial is registered with FDA with number: NCT00908323. The sponsor of the trial is National Institute of Allergy and Infectious Diseases (NIAID) and it is looking for 47 volunteers for the current phase.
Official trial title:
Characterization of the Innate Immune Response to Candidate HIV Vaccines, an Ancillary Study to HVTN 205